October Pharma S.A.E (EGX:OCPH)

Market Cap	4.69B +280.0%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	13.76 +4.4%
Shares Out	12.00M
PE Ratio	28.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,398
Average Volume	80,814
Open	395.73
Previous Close	395.73
Day's Range	386.82 - 404.80
52-Week Range	100.15 - 416.50
Beta	0.75
RSI	77.00
Earnings Date	May 25, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.